Lilly strikes second partnership this year for recombinase-based gene editingnews2026-04-28T11:00:57+00:00April 28th, 2026|Endpoints News|
Galapagos spinout Coultreon raises $125M for new take on SIK inhibitionnews2026-04-28T11:00:35+00:00April 28th, 2026|Endpoints News|
Novartis CEO disheartened by Germany’s planned €60B cuts to healthcare spendingnews2026-04-28T10:35:26+00:00April 28th, 2026|Endpoints News|
Boehringer, Zealand’s obesity shot looks as good as Novo’s Wegovy, but weaker than Lilly’s Zepboundnews2026-04-28T10:26:29+00:00April 28th, 2026|Endpoints News|
Fatal incident at US catalyst refiner under investigationnews2026-04-28T10:04:00+00:00April 28th, 2026|Chemistry World|
